These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
374 related items for PubMed ID: 1320824
21. Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo. Landolfi R, Ciabattoni G, Patrignani P, Castellana MA, Pogliani E, Bizzi B, Patrono C. Blood; 1992 Oct 15; 80(8):1965-71. PubMed ID: 1327286 [Abstract] [Full Text] [Related]
22. Difference in urinary 11-dehydro TXB2 and LTE4 excretion in patients with rheumatoid arthritis. Nakamura H, Hishinuma T, Suzuki N, Chiba S, Tsukamoto H, Takabatake M, Sawai T, Mitomo T, Inoue H, Matsumoto F, Mizugaki M. Prostaglandins Leukot Essent Fatty Acids; 2001 Oct 15; 65(5-6):301-6. PubMed ID: 11993724 [Abstract] [Full Text] [Related]
23. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Christie PE, Tagari P, Ford-Hutchinson AW, Charlesson S, Chee P, Arm JP, Lee TH. Am Rev Respir Dis; 1991 May 15; 143(5 Pt 1):1025-9. PubMed ID: 1850964 [Abstract] [Full Text] [Related]
24. Leukotrienes C4, D4, and E4 enhance histamine responsiveness in asthmatic airways. O'Hickey SP, Hawksworth RJ, Fong CY, Arm JP, Spur BW, Lee TH. Am Rev Respir Dis; 1991 Nov 15; 144(5):1053-7. PubMed ID: 1659268 [Abstract] [Full Text] [Related]
25. Persistent generation of peptido leukotrienes in patients with the adult respiratory distress syndrome. Bernard GR, Korley V, Chee P, Swindell B, Ford-Hutchinson AW, Tagari P. Am Rev Respir Dis; 1991 Aug 15; 144(2):263-7. PubMed ID: 1650152 [Abstract] [Full Text] [Related]
26. Urinary leukotriene E4 levels after allergen and exercise challenge in bronchial asthma. Smith CM, Christie PE, Hawksworth RJ, Thien F, Lee TH. Am Rev Respir Dis; 1991 Dec 15; 144(6):1411-3. PubMed ID: 1660231 [Abstract] [Full Text] [Related]
27. Urinary excretion of leukotriene E4 and 11-dehydrothromboxane B2 in patients with spontaneous asthma attacks. Oosaki R, Mizushima Y, Kawasaki A, Kashii T, Mita H, Shida T, Akiyama K, Kobayashi M. Int Arch Allergy Immunol; 1997 Dec 15; 114(4):373-8. PubMed ID: 9414142 [Abstract] [Full Text] [Related]
28. Early increase in urinary leukotriene E4 (LTE4) is dependent on allergen dose inhaled during bronchial challenge in asthmatic subjects. Bancalari L, Conti I, Giannessi D, Lazzerini G, Dente FL, De Caterina R, Paggiaro PL. Allergy; 1999 Dec 15; 54(12):1278-85. PubMed ID: 10688431 [Abstract] [Full Text] [Related]
29. Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma. Yoshida S, Amayasu H, Sakamoto H, Onuma K, Shoji T, Nakagawa H, Tajima T. Ann Allergy Asthma Immunol; 1998 Feb 15; 80(2):171-6. PubMed ID: 9494450 [Abstract] [Full Text] [Related]
30. Urinary leukotriene E4 and 11-dehydrothromboxane B2 in patients with aspirin-sensitive asthma. Oosaki R, Mizushima Y, Mita H, Shida T, Akiyama K, Kobayashi M. Allergy; 1997 Apr 15; 52(4):470-3. PubMed ID: 9188934 [Abstract] [Full Text] [Related]
31. Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4. Dahlén SE, Hansson G, Hedqvist P, Björck T, Granström E, Dahlén B. Proc Natl Acad Sci U S A; 1983 Mar 15; 80(6):1712-6. PubMed ID: 6300870 [Abstract] [Full Text] [Related]
32. Urinary leukotriene E4 excretion in exercise-induced asthma. Taylor IK, Wellings R, Taylor GW, Fuller RW. J Appl Physiol (1985); 1992 Aug 15; 73(2):743-8. PubMed ID: 1328140 [Abstract] [Full Text] [Related]
33. The challenge procedure influences the extent of allergen-induced urinary excretion of leukotriene E4. Kumlin M, Dahlén B. Clin Exp Allergy; 2000 Apr 15; 30(4):585-9. PubMed ID: 10718858 [Abstract] [Full Text] [Related]
34. [Urinary leukotriene E4 concentration in patients with bronchial asthma and intolerance of non-steroids anti-inflammatory drugs before and after oral aspirin challenge]. Rubinsztajn R, Wrońska J, Chazan R. Pol Arch Med Wewn; 2003 Aug 15; 110(2):849-54. PubMed ID: 14682223 [Abstract] [Full Text] [Related]
35. Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction. O'Shaughnessy KM, Taylor IK, O'Connor B, O'Connell F, Thomson H, Dollery CT. Am Rev Respir Dis; 1993 Jun 15; 147(6 Pt 1):1431-5. PubMed ID: 8389105 [Abstract] [Full Text] [Related]
36. Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics. Macfarlane AJ, Dworski R, Sheller JR, Pavord ID, Kay AB, Barnes NC. Am J Respir Crit Care Med; 2000 May 15; 161(5):1553-8. PubMed ID: 10806153 [Abstract] [Full Text] [Related]
37. Urinary LTE4 is higher after nasal provocation test with L-ASA in bronchial than in only nasal responders. Micheletto C, Visconti M, Tognella S, Trevisan F, Dal Negro RW. Eur Ann Allergy Clin Immunol; 2007 May 15; 39(5):162-6. PubMed ID: 17626331 [Abstract] [Full Text] [Related]
38. The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics. Dahlén B, Zetterström O, Björck T, Dahlén SE. Eur Respir J; 1994 Feb 15; 7(2):324-31. PubMed ID: 8162986 [Abstract] [Full Text] [Related]
39. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. Obase Y, Shimoda T, Tomari SY, Mitsuta K, Kawano T, Matsuse H, Kohno S. Chest; 2002 Jan 15; 121(1):143-50. PubMed ID: 11796443 [Abstract] [Full Text] [Related]
40. Urinary leukotriene E4 levels during early and late asthmatic responses. Manning PJ, Rokach J, Malo JL, Ethier D, Cartier A, Girard Y, Charleson S, O'Byrne PM. J Allergy Clin Immunol; 1990 Aug 15; 86(2):211-20. PubMed ID: 2166758 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]